A range of AEs has previously been reported as class effects of drugs targeting the VEGF pathway.34, 35, 36, 37, 38, 39, 40 Of these, hypertension and proteinuria were the only two reported in at least 10% of patients in either arm of the present study, with similar incidences in both treatment groups. This evidence concerns the gene VEGFA and hypertensive disorder.